Phase I, Open-label, Dose Escalation of AZD4877 in Hematologic Malignancies

Summary

The primary purpose of this study is to find out what the maximum tolerated dose is for an experimental drug called AZD4877 based on the side effects experienced by patients that receive AZD4877 on a weekly basis in these diseases.

Timeline

Start

2007-03

Primary completion

—

Completion

2007-08

Outcome

Outcome not reported

Stopped (Enrollment): “Study was terminated due to low enrollment”

Drugs

Indications